Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally
Identifieur interne : 001930 ( Ncbi/Merge ); précédent : 001929; suivant : 001931Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally
Auteurs : Maria Julia Marinissen ; Lauren Barna ; Margaret Meyers ; Susan E. ShermanSource :
- Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science [ 1538-7135 ] ; 2014.
Descripteurs français
- KwdFr :
- Accessibilité des services de santé, Animaux, Bioterrorisme (), Bioterrorisme (législation et jurisprudence), Contrôle des maladies contagieuses (législation et jurisprudence), Contrôle des maladies contagieuses (organisation et administration), Coopération internationale (législation et jurisprudence), Flambées de maladies (), Flambées de maladies (législation et jurisprudence), Grippe humaine (), Grippe humaine (épidémiologie), Humains, Mesures de sécurité, Objectifs de fonctionnement, Organisation mondiale de la santé, Renforcement des capacités, Santé mondiale (législation et jurisprudence), Sous-type H1N1 du virus de la grippe A.
- MESH :
- législation et jurisprudence : Bioterrorisme, Contrôle des maladies contagieuses, Coopération internationale, Flambées de maladies, Santé mondiale.
- organisation et administration : Contrôle des maladies contagieuses.
- épidémiologie : Grippe humaine.
- Accessibilité des services de santé, Animaux, Bioterrorisme, Flambées de maladies, Grippe humaine, Humains, Mesures de sécurité, Objectifs de fonctionnement, Organisation mondiale de la santé, Renforcement des capacités, Sous-type H1N1 du virus de la grippe A.
English descriptors
- KwdEn :
- Animals, Bioterrorism (legislation & jurisprudence), Bioterrorism (prevention & control), Capacity Building, Communicable Disease Control (legislation & jurisprudence), Communicable Disease Control (organization & administration), Disease Outbreaks (legislation & jurisprudence), Disease Outbreaks (prevention & control), Global Health (legislation & jurisprudence), Health Services Accessibility, Humans, Influenza A Virus, H1N1 Subtype, Influenza, Human (epidemiology), Influenza, Human (prevention & control), International Cooperation (legislation & jurisprudence), Organizational Objectives, Security Measures, World Health Organization.
- MESH :
- epidemiology : Influenza, Human.
- legislation & jurisprudence : Bioterrorism, Communicable Disease Control, Disease Outbreaks, Global Health, International Cooperation.
- organization & administration : Communicable Disease Control.
- prevention & control : Bioterrorism, Disease Outbreaks, Influenza, Human.
- Animals, Capacity Building, Health Services Accessibility, Humans, Influenza A Virus, H1N1 Subtype, Organizational Objectives, Security Measures, World Health Organization.
Abstract
In 2014, the United States in partnership with international organizations and nearly 30 partner countries launched the Global Health Security Agenda (GHSA) to accelerate progress to improve prevention, detection, and response capabilities for infectious disease outbreaks that can cause public health emergencies. Objective 9 of the GHSA calls for improved global access to medical countermeasures and establishes as a target the development of national policy frameworks for sending and receiving medical countermeasures from and to international partners during public health emergencies. The term
Url:
DOI: 10.1089/bsp.2014.0049
PubMed: 25254917
PubMed Central: 4170983
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000656
- to stream Pmc, to step Curation: 000656
- to stream Pmc, to step Checkpoint: 000429
- to stream PubMed, to step Corpus: 000755
- to stream PubMed, to step Curation: 000755
- to stream PubMed, to step Checkpoint: 001F18
Links to Exploration step
PMC:4170983Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E." last="Sherman">Susan E. Sherman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25254917</idno><idno type="pmc">4170983</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170983</idno><idno type="RBID">PMC:4170983</idno><idno type="doi">10.1089/bsp.2014.0049</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000656</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000656</idno><idno type="wicri:Area/Pmc/Curation">000656</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000656</idno><idno type="wicri:Area/Pmc/Checkpoint">000429</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000429</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:25254917</idno><idno type="wicri:Area/PubMed/Corpus">000755</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000755</idno><idno type="wicri:Area/PubMed/Curation">000755</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000755</idno><idno type="wicri:Area/PubMed/Checkpoint">001F18</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F18</idno><idno type="wicri:Area/Ncbi/Merge">001930</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E." last="Sherman">Susan E. Sherman</name></author></analytic><series><title level="j">Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science</title><idno type="ISSN">1538-7135</idno><idno type="eISSN">1557-850X</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Bioterrorism (legislation & jurisprudence)</term><term>Bioterrorism (prevention & control)</term><term>Capacity Building</term><term>Communicable Disease Control (legislation & jurisprudence)</term><term>Communicable Disease Control (organization & administration)</term><term>Disease Outbreaks (legislation & jurisprudence)</term><term>Disease Outbreaks (prevention & control)</term><term>Global Health (legislation & jurisprudence)</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>International Cooperation (legislation & jurisprudence)</term><term>Organizational Objectives</term><term>Security Measures</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Animaux</term><term>Bioterrorisme ()</term><term>Bioterrorisme (législation et jurisprudence)</term><term>Contrôle des maladies contagieuses (législation et jurisprudence)</term><term>Contrôle des maladies contagieuses (organisation et administration)</term><term>Coopération internationale (législation et jurisprudence)</term><term>Flambées de maladies ()</term><term>Flambées de maladies (législation et jurisprudence)</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Mesures de sécurité</term><term>Objectifs de fonctionnement</term><term>Organisation mondiale de la santé</term><term>Renforcement des capacités</term><term>Santé mondiale (législation et jurisprudence)</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Bioterrorism</term><term>Communicable Disease Control</term><term>Disease Outbreaks</term><term>Global Health</term><term>International Cooperation</term></keywords><keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Bioterrorisme</term><term>Contrôle des maladies contagieuses</term><term>Coopération internationale</term><term>Flambées de maladies</term><term>Santé mondiale</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Contrôle des maladies contagieuses</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bioterrorism</term><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Capacity Building</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Organizational Objectives</term><term>Security Measures</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Animaux</term><term>Bioterrorisme</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Mesures de sécurité</term><term>Objectifs de fonctionnement</term><term>Organisation mondiale de la santé</term><term>Renforcement des capacités</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>In 2014, the United States in partnership with international organizations and nearly 30 partner countries launched the Global Health Security Agenda (GHSA) to accelerate progress to improve prevention, detection, and response capabilities for infectious disease outbreaks that can cause public health emergencies. Objective 9 of the GHSA calls for improved global access to medical countermeasures and establishes as a target the development of national policy frameworks for sending and receiving medical countermeasures from and to international partners during public health emergencies. The term <italic>medical countermeasures</italic> refers to vaccines, antimicrobials, therapeutics, and diagnostics that address the public health and medical consequences of chemical, biological, radiological, and nuclear events; pandemic influenza; and emerging infectious diseases. They are stockpiled by a few countries to protect their own populations and by international organizations, such as the World Health Organization (WHO), for the international community, typically for recipients with limited resources. However, as observed during the 2009 H1N1 influenza pandemic, legal, regulatory, logistical, and funding barriers slowed the ability of WHO and countries to quickly deploy or receive vaccine. Had the 2009 H1N1 influenza pandemic been more severe, the world would have been ill prepared to cope with the global demand for rapid access to medical countermeasures. This article summarizes the US government efforts to develop a national framework to deploy medical countermeasures internationally and a number of engagements to develop regional and international mechanisms, thus increasing global capacity to respond to public health emergencies.</p></div></front></TEI><double pmid="25254917"><pmc><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E." last="Sherman">Susan E. Sherman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25254917</idno><idno type="pmc">4170983</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170983</idno><idno type="RBID">PMC:4170983</idno><idno type="doi">10.1089/bsp.2014.0049</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000656</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000656</idno><idno type="wicri:Area/Pmc/Curation">000656</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000656</idno><idno type="wicri:Area/Pmc/Checkpoint">000429</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000429</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E." last="Sherman">Susan E. Sherman</name></author></analytic><series><title level="j">Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science</title><idno type="ISSN">1538-7135</idno><idno type="eISSN">1557-850X</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>In 2014, the United States in partnership with international organizations and nearly 30 partner countries launched the Global Health Security Agenda (GHSA) to accelerate progress to improve prevention, detection, and response capabilities for infectious disease outbreaks that can cause public health emergencies. Objective 9 of the GHSA calls for improved global access to medical countermeasures and establishes as a target the development of national policy frameworks for sending and receiving medical countermeasures from and to international partners during public health emergencies. The term <italic>medical countermeasures</italic> refers to vaccines, antimicrobials, therapeutics, and diagnostics that address the public health and medical consequences of chemical, biological, radiological, and nuclear events; pandemic influenza; and emerging infectious diseases. They are stockpiled by a few countries to protect their own populations and by international organizations, such as the World Health Organization (WHO), for the international community, typically for recipients with limited resources. However, as observed during the 2009 H1N1 influenza pandemic, legal, regulatory, logistical, and funding barriers slowed the ability of WHO and countries to quickly deploy or receive vaccine. Had the 2009 H1N1 influenza pandemic been more severe, the world would have been ill prepared to cope with the global demand for rapid access to medical countermeasures. This article summarizes the US government efforts to develop a national framework to deploy medical countermeasures internationally and a number of engagements to develop regional and international mechanisms, thus increasing global capacity to respond to public health emergencies.</p></div></front></TEI></pmc><pubmed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strengthening global health security by developing capacities to deploy medical countermeasures internationally.</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E" last="Sherman">Susan E. Sherman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2014 Sep-Oct</MedlineDate></PubDate></date><idno type="RBID">pubmed:25254917</idno><idno type="pmid">25254917</idno><idno type="doi">10.1089/bsp.2014.0049</idno><idno type="wicri:Area/PubMed/Corpus">000755</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000755</idno><idno type="wicri:Area/PubMed/Curation">000755</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000755</idno><idno type="wicri:Area/PubMed/Checkpoint">001F18</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Strengthening global health security by developing capacities to deploy medical countermeasures internationally.</title><author><name sortKey="Marinissen, Maria Julia" sort="Marinissen, Maria Julia" uniqKey="Marinissen M" first="Maria Julia" last="Marinissen">Maria Julia Marinissen</name></author><author><name sortKey="Barna, Lauren" sort="Barna, Lauren" uniqKey="Barna L" first="Lauren" last="Barna">Lauren Barna</name></author><author><name sortKey="Meyers, Margaret" sort="Meyers, Margaret" uniqKey="Meyers M" first="Margaret" last="Meyers">Margaret Meyers</name></author><author><name sortKey="Sherman, Susan E" sort="Sherman, Susan E" uniqKey="Sherman S" first="Susan E" last="Sherman">Susan E. Sherman</name></author></analytic><series><title level="j">Biosecurity and bioterrorism : biodefense strategy, practice, and science</title><idno type="eISSN">1557-850X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Bioterrorism (legislation & jurisprudence)</term><term>Bioterrorism (prevention & control)</term><term>Capacity Building</term><term>Communicable Disease Control (legislation & jurisprudence)</term><term>Communicable Disease Control (organization & administration)</term><term>Disease Outbreaks (legislation & jurisprudence)</term><term>Disease Outbreaks (prevention & control)</term><term>Global Health (legislation & jurisprudence)</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>International Cooperation (legislation & jurisprudence)</term><term>Organizational Objectives</term><term>Security Measures</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Animaux</term><term>Bioterrorisme ()</term><term>Bioterrorisme (législation et jurisprudence)</term><term>Contrôle des maladies contagieuses (législation et jurisprudence)</term><term>Contrôle des maladies contagieuses (organisation et administration)</term><term>Coopération internationale (législation et jurisprudence)</term><term>Flambées de maladies ()</term><term>Flambées de maladies (législation et jurisprudence)</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Mesures de sécurité</term><term>Objectifs de fonctionnement</term><term>Organisation mondiale de la santé</term><term>Renforcement des capacités</term><term>Santé mondiale (législation et jurisprudence)</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Bioterrorism</term><term>Communicable Disease Control</term><term>Disease Outbreaks</term><term>Global Health</term><term>International Cooperation</term></keywords><keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Bioterrorisme</term><term>Contrôle des maladies contagieuses</term><term>Coopération internationale</term><term>Flambées de maladies</term><term>Santé mondiale</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Contrôle des maladies contagieuses</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bioterrorism</term><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Capacity Building</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Organizational Objectives</term><term>Security Measures</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Animaux</term><term>Bioterrorisme</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Mesures de sécurité</term><term>Objectifs de fonctionnement</term><term>Organisation mondiale de la santé</term><term>Renforcement des capacités</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2014, the United States in partnership with international organizations and nearly 30 partner countries launched the Global Health Security Agenda (GHSA) to accelerate progress to improve prevention, detection, and response capabilities for infectious disease outbreaks that can cause public health emergencies. Objective 9 of the GHSA calls for improved global access to medical countermeasures and establishes as a target the development of national policy frameworks for sending and receiving medical countermeasures from and to international partners during public health emergencies. The term medical countermeasures refers to vaccines, antimicrobials, therapeutics, and diagnostics that address the public health and medical consequences of chemical, biological, radiological, and nuclear events; pandemic influenza; and emerging infectious diseases. They are stockpiled by a few countries to protect their own populations and by international organizations, such as the World Health Organization (WHO), for the international community, typically for recipients with limited resources. However, as observed during the 2009 H1N1 influenza pandemic, legal, regulatory, logistical, and funding barriers slowed the ability of WHO and countries to quickly deploy or receive vaccine. Had the 2009 H1N1 influenza pandemic been more severe, the world would have been ill prepared to cope with the global demand for rapid access to medical countermeasures. This article summarizes the US government efforts to develop a national framework to deploy medical countermeasures internationally and a number of engagements to develop regional and international mechanisms, thus increasing global capacity to respond to public health emergencies. </div></front></TEI></pubmed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001930 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001930 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:4170983
|texte= Strengthening Global Health Security by Developing Capacities to Deploy Medical Countermeasures Internationally
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25254917" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |